| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |